Vildagliptin shows good hepatic/pancreatic safety profile

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1278, 2009-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The hepatic safety profile of duloxetine: a review

By McIntyre Roger S   Panjwani Zilomi D   Nguyen Ha T   Woldeyohannes Hanna O   Alsuwaidan Mohammad   Soczynska Joanna K   Lourenco Maria T   Konarski Jakub Z   Kennedy Sidney H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 281-285

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 3, 2007-03 ,pp. : 4-6

Adis International

Access to resources Recommend Favorite

Anti-Adhesion Molecules: is Gut Specificity the Key for a Good Safety Profile?

By  

Current Drug Delivery, Vol. 9, Iss. 4, 2012-07 ,pp. : 333-337

Bentham Science Publishers

Access to resources Recommend Favorite

Vildagliptin

By Henness Sheridan   Keam Susan J.  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1989-2001

Adis International

Access to resources Recommend Favorite

Adjuvanted H5N1 influenza vaccine offers good safety profile

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite